The predictive capacity of in vitro preclinical models to evaluate drugs for the treatment of retinoblastoma. Sinenko IL, Turnell-Ritson RC, Munier FL, Dyson PJ, et al. Exp Eye Res 2023 Mar 18:109447. doi: 10.1016/j.exer.2023.109447.

Read + Share

Amedeo Smart

Independent Medical Education

Sinenko IL, Turnell-Ritson RC, Munier FL, Dyson PJ, et al. The predictive capacity of in vitro preclinical models to evaluate drugs for the treatment of retinoblastoma. Exp Eye Res 2023 Mar 18:109447. doi: 10.1016/j.exer.2023.109447.
PMID: 36940901